(MRVI) Maravai Lifesciences - Performance -65.3% in 12m
MRVI performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-92.86%
#52 in Peer-Group
Rel. Strength
6.30%
#6959 in Stock-Universe
Total Return 12m
-65.27%
#45 in Peer-Group
Total Return 5y
-91.93%
#48 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 370 |
| High / Low | USD |
|---|---|
| 52 Week High | 9.73 USD |
| 52 Week Low | 1.72 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 82.06 |
| Buy/Sell Signal +-5 | 1.89 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MRVI (-65.3%) vs XLV (-5.4%)
5y Drawdown (Underwater) Chart
Top Performer in Life Sciences Tools & Services
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| A NYSE Agilent Technologies |
6.27% | -6.68% | 37.4% | 29.2 | 21.2 | 1.93 | 45.2% | 4.46% |
| TMO NYSE Thermo Fisher Scientific |
2.37% | -24.9% | 12.2% | 23.8 | 17.5 | 1.51 | -28.9% | -3.66% |
| IQV NYSE IQVIA Holdings |
13.3% | -24.4% | 11.4% | 21.5 | 13.4 | 0.98 | 56.0% | 11.7% |
| QGEN NYSE Qiagen |
7.04% | 19.4% | 12.8% | 112 | 19.6 | 1.08 | -56.7% | -5.77% |
| RVTY NYSE Revvity |
8.28% | -5.86% | -0.14% | 39.2 | 19.3 | 0.71 | -51.9% | -36.8% |
| EKTA-B ST Elekta (publ) |
-1.85% | -22.9% | -35.5% | 77 | 12.8 | 1.32 | 16.6% | 1.38% |
Performance Comparison: MRVI vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for MRVI
| Total Return (including Dividends) | MRVI | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 13.15% | 2.04% | 4.55% |
| 3 Months | 9.05% | -7.24% | 10.78% |
| 12 Months | -65.27% | -5.41% | 14.71% |
| 5 Years | -91.93% | 43.58% | 112.53% |
| Trend Score (consistency of price movement) | MRVI | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 17.2% | 34.5% | 79.2% |
| 3 Months | 64.2% | -46.5% | 92.9% |
| 12 Months | -92.7% | -71.8% | 44.2% |
| 5 Years | -92.8% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th47.06 | 10.88% | 8.22% |
| 3 Month | %th66.67 | 17.57% | -1.56% |
| 12 Month | %th15.69 | -63.29% | -69.73% |
| 5 Years | %th9.80 | -93.95% | -95.66% |
FAQs
Does Maravai Lifesciences (MRVI) outperform the market?
No,
over the last 12 months MRVI made -65.27%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.41%.
Over the last 3 months MRVI made 9.05%, while XLV made -7.24%.
Performance Comparison MRVI vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MRVI vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 11.3% | 8.6% | -61.8% | -80% |
| US NASDAQ 100 | QQQ | 10.5% | 7.6% | -64% | -80% |
| German DAX 40 | DAX | 11.4% | 13.2% | -74.8% | -95% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 11.6% | 9% | -59.8% | -83% |
| Hongkong Hang Seng | HSI | 11.7% | 7.4% | -77.6% | -101% |
| India NIFTY 50 | INDA | 11.7% | 11.1% | -61.6% | -65% |
| Brasil Bovespa | EWZ | 9.9% | 5.4% | -86.3% | -79% |
MRVI vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 9.8% | 6.4% | -68.5% | -94% |
| Consumer Discretionary | XLY | 12.9% | 11.5% | -53.1% | -85% |
| Consumer Staples | XLP | 14.8% | 14.8% | -60% | -74% |
| Energy | XLE | 15.6% | 9.6% | -56.4% | -61% |
| Financial | XLF | 11.2% | 10.1% | -64.9% | -94% |
| Health Care | XLV | 12.2% | 11.1% | -54.6% | -60% |
| Industrial | XLI | 11.7% | 9.4% | -68.4% | -89% |
| Materials | XLB | 13.2% | 11.5% | -61.2% | -68% |
| Real Estate | XLRE | 15.7% | 13.1% | -59.2% | -78% |
| Technology | XLK | 10% | 4.3% | -65.1% | -77% |
| Utilities | XLU | 13.7% | 13.1% | -65.2% | -89% |
| Aerospace & Defense | XAR | 9.3% | 3.3% | -83.2% | -118% |
| Biotech | XBI | 13.4% | 11.1% | -47.9% | -54% |
| Homebuilder | XHB | 13% | 7.1% | -50.6% | -66% |
| Retail | XRT | 14.4% | 11.7% | -53.1% | -71% |
MRVI vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 18.5% | 8.03% | -52.6% | -55% |
| Natural Gas | UNG | 23.5% | 22.6% | -46.7% | -57% |
| Gold | GLD | 16.2% | 15.3% | -81.7% | -107% |
| Silver | SLV | 14.7% | 9.3% | -80.4% | -87% |
| Copper | CPER | 11% | 9% | -81.5% | -80% |
MRVI vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 12.5% | 9.5% | -58.6% | -67% |
| iShares High Yield Corp. Bond | HYG | 13.3% | 11.3% | -60.8% | -76% |